Positive late stage rheumatoid arthritis trial results for Abbvie - PharmaTimes

Positive late stage rheumatoid arthritis trial results for Abbvie  PharmaTimes

Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.



Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network